HRAS and thyroid nodule: Our results align with previous findings that EIF1AX mutations occur in both benign and malignant thyroid nodules, and that they also coexist with other driver mutations including NRAS, HRAS, TP53, TERT, and PIK3CA in a significant proportion of cases.